Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible

James A. Hutchinson, Felix Gövert, Paloma Riquelme, Jan Hinrich Bräsen, Beate G. Brem-Exner, Martina Matthäi, Maren Schulze, Lutz Renders, Ulrich Kunzendorf, Edward K. Geissler, Fred Fändrich

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Patient KW, a 36-yr-old male renal transplant recipient, received transplant acceptance-inducing cells (TAICs) as an adjunct immunosuppressive therapy. In the weeks post-transplantation, the patient's conventional immunosuppressive treatment was gradually minimized, such that, from the 21st wk post-transplantation onwards, the patient was stably maintained on tacrolimus monotherapy. Treatment with TAICs was without complication, both at the time of administration and in the four-yr follow-up period. It is concluded that the production and administration of TAICs to recipients of kidney transplants from deceased donors is technically feasible.

Original languageEnglish
Pages (from-to)140-145
Number of pages6
JournalClinical Transplantation
Volume23
Issue number1
DOIs
StatePublished - 2009
Externally publishedYes

Keywords

  • Cell-based immunotherapy
  • Regulatory macrophage

Fingerprint

Dive into the research topics of 'Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible'. Together they form a unique fingerprint.

Cite this